Sort
17,288 grants matching “multiple sclerosis”
AN OVERLOOKED K+ CURRENT REPOLARIZES ACTION POTENTIALS THROUGHOUT THE BRAIN
$228,750Lawrence B Salkoff · Washington University · R21 · FY2016 · NS
Encapsulated Active Vitamin D Vaccine for the Treatment of Multiple Sclerosis
$228,750Kristy M Ainslie · Ohio State University · R21 · FY2011 · NS
Characterization of ATXN2 as a target for ALS in SCA2 motor neurons
$228,750Stefan M. Pulst · University Of Utah · R21 · FY2019 · NS
The role of Kainate receptors in oligodendrocyte toxicity and EAE
$228,750Geoffrey T Swanson · Northwestern University At Chicago · R21 · FY2010 · NS
Probing Biomolecular Condensates in Live Cells using Microsecond-scale Single Molecule Rotational Diffusion Microscopy (µs-SiMRoD)
$228,750Siegfried M Musser · Texas A&M University Health Science Ctr · R21 · FY2025 · NS
NOVEL ANTIVIRAL IMMUNITY IN C. ELEGANS
$228,750David Wang · Washington University · R21 · FY2015 · AI
An Immune Tolerance Strategy for Prevention and Treatment of Atherosclerosis
$228,750Jayme Borensztajn · Northwestern University At Chicago · R21 · FY2010 · HL
Mechanisms of sex differences in blood-brain barrier biology
$228,750Robyn S Klein · Washington University · R21 · FY2017 · NS
Ikaros in mast vs. basophil lineage choice
$228,750Melissa Ann Brown · Northwestern University At Chicago · R21 · FY2010 · AI
Role of dysregulated miRNA in Tregs in Multiple Sclerosis
$228,750Amy E Lovett-Racke · Ohio State University · R21 · FY2012 · NS
Stress Hormone-Mediated Reactivation of Latent Epstein-Barr Virus
$228,750Jeanette Irene Marketon · Ohio State University · R21 · FY2012 · AI
The role of regulatory T cells in maintaining B cell tolerance
$228,750Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R21 · FY2006 · AI
MicroRNA Modulation of Immune Function in Multiple Sclerosis
$228,750Caroline C Whitacre · Ohio State University · R21 · FY2011 · AI
Mining the Multiple Sclerosis miRNome for Disease Markers
$228,750Amy E Lovett-Racke · Ohio State University · R21 · FY2009 · NS
CaMKIIbeta: a regulator of CNS myelination
$228,750Babette Fuss · Virginia Commonwealth University · R21 · FY2015 · NS
Regulatory myeloid cells in inflammatory disease: Therapy and targeted generatio
$228,750Tracey L Papenfuss · Ohio State University · R21 · FY2012 · AI
Quantitative evaluation of 3D mouse behaviors in the open field using markerless
$228,750Michele M Basso · Ohio State University · R21 · FY2011 · NS
Nanotechnology-based transcription core
$228,691Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2015 · AI
MYELIN PO GLYCOPROTEIN: STRUCTURE &ADHESIVE MECHANISMS
$228,636Boston College · R01 · FY2000 · NS
Visual outcome measures in children with optic Pathway gliomas
$228,593Robert Andrew Avery · Children'S Hosp Of Philadelphia · K23 · FY2016 · EY
Alu dsRNAs as adjuvants for influenza vaccines
$228,562Thomas M. Aune · Vanderbilt University Medical Center · R21 · FY2022 · AI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma
$228,510Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2015 · TR
MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN SOUTHEASTERN MINNESOTA
$228,401Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2002 · CA
Conditional deletion of Mapt in the adult mouse brain
$228,400Ruben Vidal · Indiana University Indianapolis · R21 · FY2016 · NS
Segmentation and volumetric quantification of thalamic nuclei for assessing MS
$228,293Jerry L Prince · Johns Hopkins University · R21 · FY2014 · NS